In addition, patients with PD-1+ TILs were more likely than patients without PD-1+ TILs to have larger tumors, tumors of higher nuclear grade, advanced tumor node-metastasis stage, coagulative tumor necrosis, and sarcomatoid differentiation. This evidence concerns the gene PDCD1 and neoplasm.